52-Week Performance Chart

Powered by FactSet Research Systems Inc

Corporate Actions/Books Closed

More
Oct 09, 2023
Adlai Nortye Ltd. - Books Closed / Open for Issuance
Oct 03, 2023
Adlai Nortye Ltd - New Depositary Receipt Announcement

Capital Raising Events

More
DR Price Date DR Price (USD) US/Non-US/Total DRS US/Non-US/Total DR Capital Raised
Sep 29, 2023 23.00 2,500,000
0
2,500,000
57,500,000
0
57,500,000

No DR Special Notices are available.

Data provided by Thomson Reuters

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
Cantor Fitzgerald & Co. 40,310
Millennium Management LLC 11,556
UBS Securities LLC 4,675
TOP MUTUAL FUND HOLDERS POSITION

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol ANL
CUSIP 00704R109
DR Venue NASDAQ Stock Market
DR ISIN US00704R1095
Ratio DR:ORD 1:3
Local Exchange Not Traded
Underlying ISIN KY009A8IIB21
Country China
Effective Date Oct 03, 2023
Depositary BK (Sponsored)
Industry Pharma. & Biotech.
Books Open/Closed Open
Adlai Nortye Ltd is a Cayman Island-based clinical-stage biotechnology company. The Company is engaged in the discovery and development of cancer therapies. The Company's pipeline includes three clinical-stage drug candidates, buparlisib (AN2025), palupiprant (AN0025), and AN4005, as well as three preclinical candidates. AN2025 is a pan-phosphoinositide 3-kinase (PI3K) inhibitor that is designed to act against solid tumors. AN2025 is undergoing Phase III, open-label clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas (HNSCC) after anti-programmed death-1 (PD-1) or its ligand (PD-L1) treatment.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Annual Depositary Service up to $0.0500
Cancellation up to $0.0500
Cash Distribution up to $0.0500
Issuance up to $0.0500
Registrar Inspection up to $0.0000
Cash Distribution(Other) up to $0.0500
Rights - Issuance up to $0.0500
Stock Dividend up to $0.0500
Transfer up to $0.0000
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
May.25 1.82 201,294 10,594
Apr.25 1.84 592,441 29,622
Mar.25 2.01 137,064 6,527

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE